Dapsone as corticosteroid-sparing therapy for Sweet syndrome

J Am Acad Dermatol. 2022 Mar;86(3):677-679. doi: 10.1016/j.jaad.2021.02.067. Epub 2021 Mar 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Dapsone* / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Sweet Syndrome* / diagnosis
  • Sweet Syndrome* / drug therapy

Substances

  • Adrenal Cortex Hormones
  • Dapsone